Altos Biologics
Latest round
- Series B
Last raised
- Jul 2024
Total raised
- $73M
Investors
- 8
About Altos Biologics
Altos Biologics, founded in 2020 and headquartered in Daejeon, South Korea, specializes in biotechnological solutions aimed at addressing critical health issues.ALTOS Biologics specializes in biotechnological solutions aimed at addressing critical health challenges. The company offers a range of services, including the development and delivery of biologics tailored for therapeutic applications. These products function to enhance patient outcomes in various medical fields, including oncology and immunology, effectively targeting specific health issues through innovative biologic agents. ALTOS Biologics serves a diverse clientele that encompasses healthcare providers, research institutions, and pharmaceutical companies, primarily in the Asian markets, including but not limited to South Korea, Japan, and China.ALTOS Biologics generates revenue through a structured model that includes B2B partnerships and direct service offerings to healthcare providers and institutions. The company's revenue streams are primarily derived from biopharmaceutical product sales and ongoing service contracts, which facilitate access to their advanced biologic therapies. Transactions typically involve long-term agreements with hospitals and clinics, where ALTOS provides tailored biologic solutions based on specific clinical needs. The pricing structure for these services is designed to reflect the complexity and innovation of their product offerings, aligning costs with the value delivered to healthcare professionals and end patients. Additionally, Altos Biologics aims to expand its reach into new markets, specifically targeting regions in Asia beyond South Korea, including Japan and China, by the end of 2025.
Who invested in Altos Biologics
8 investors across 3 rounds
See all investors in Altos Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Altos Biologics
Who invested in Altos Biologics?
Altos Biologics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Altos Biologics raised?
Altos Biologics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Altos Biologics last raise money?
Altos Biologics's most recent round on record is a Series B, in Jul 2024.
What does Altos Biologics do?
Altos Biologics, founded in 2020 and headquartered in Daejeon, South Korea, specializes in biotechnological solutions aimed at addressing critical health issues.
Where is Altos Biologics headquartered?
Altos Biologics is headquartered in Daejeon, South Korea.
Which VCs invest in companies like Altos Biologics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Altos Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Altos Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.